DH20931

Cat. No.: HY-183140: Data Sheet Handling Instructions
FAQs
Technical Support

DH20931 is a ceramide synthase 2 (CerS2) activator. DH20931 inhibits growth of cancer cells by inducing lipotoxic endoplasmic reticulum (ER) stress. DH20931 shows synergistic anti-tumor efficacy with Doxorubicin (HY-15142A). DH20931 can be used for the research of breast cancer.

For research use only. We do not sell to patients.

DH20931 Chemical Structure

CAS No. : 1629992-28-4

Size		Stock
MOQ		Minimum order quantity
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Acyltransferase Isoform Specific Products:

View All Isoforms

ACAT1 ACAT2 MGAT2 ACAT DGAT1 DGAT2

View All Caspase Isoform Specific Products:

View All Isoforms

Caspase 1 Caspase 2 Caspase 3 Caspase 4 Caspase 5 Caspase 6 Caspase 7 Caspase 8 Caspase 9 Caspase 10 Caspase 12 Caspase Caspase 11 Caspase-13

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target^[2]

Caspase 3

In Vitro

DH20931 potently inhibits the growth of MDA-MB231, MDA-MB468, BT474, MCF7, and T47D cancer cells with IC₅₀ values of 3.9, 1.8, 0.3, 1.3 and 1.0 μM^[1].
DH20931 significantly reduces the required IC₅₀ of Doxorubicin (HY-15142A) by 3-8-fold, resulting in hyper-activation of the UPR, maximized ATF4/CHOP/PUMA expression, and a marked increase in cleaved caspase-3^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

368.86

Formula

C₂₁H₂₁ClN₂O₂

CAS No.

1629992-28-4

SMILES

COC1=CC=C2C3=C4C5=C(CCN4C=[N+]3CCC2=C1)C=C(C=C5)OC.[Cl-]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Jaiswal AS, et al. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers. Bioorg Med Chem Lett. 2014;24(20):4850-4853. [Content Brief]

[2]. Alatawi H, et al. A novel CerS2 activator, DH20931, synergizes with doxorubicin to overcome therapeutic resistance in breast cancer[J]. Cancer Research, 2026, 86(7_Supplement): 4457-4457.

DH20931 Related Classifications

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass		Concentration		Volume		Molecular Weight *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)	×	Volume _(start)	=	Concentration _(final)	×	Volume _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

DH209311629992-28-4DH 20931DH-20931AcyltransferaseCaspaseDiacylglycerol acyltransferaseDiglyceride acyltransferaseacyl-CoA:cholesterol acyltransferasemono- acylglycerol acyltransferaseMDA-MB231MDA-MB468BT474MCF7T47Dbreast cancerInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Requested Quantity *

Applicant Name *

Salutation

Email Address *

Phone Number *

Department

Organization Name *

City

State

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Email Address *

Phone Number

Department *